PhRMA Sees Canadian Currency Devaluation As Grounds For Trade Action

PhRMA believes that the inability of pharmaceutical manufacturers to raise prices in Canada to reflect the devaluation of the Canadian dollar is "contrary to the spirit" of the North American Free Trade Agreement.